Atjaunināt sīkdatņu piekrišanu

Essentials of Restenosis: For the Interventional Cardiologist 2007 ed. [Hardback]

  • Formāts: Hardback, 458 pages, height x width: 254x178 mm, weight: 1226 g, XXX, 458 p., 1 Hardback
  • Sērija : Contemporary Cardiology
  • Izdošanas datums: 27-Aug-2007
  • Izdevniecība: Humana Press Inc.
  • ISBN-10: 1588294919
  • ISBN-13: 9781588294913
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 180,78 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 212,69 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 458 pages, height x width: 254x178 mm, weight: 1226 g, XXX, 458 p., 1 Hardback
  • Sērija : Contemporary Cardiology
  • Izdošanas datums: 27-Aug-2007
  • Izdevniecība: Humana Press Inc.
  • ISBN-10: 1588294919
  • ISBN-13: 9781588294913
Citas grāmatas par šo tēmu:
Duckers (Thoraxcenter, Erasmus Medical Center Rotterdam, The Netherlands) et al. compile 27 chapters that explore the process of restenosis in this volume meant for practicing interventional cardiologists and vascular biologists, as well as medical students. They provide an overview of the molecular basis and clinical approach to its imaging, prevention, and treatment, describing the molecular and genetic basis, histomorphology, animal models, and therapeutic effects in the diagnosis and management of the cardiovascular patient. They also detail advances in invasive and non-invasive imaging of vascular lesions, as well as treatment. Contributors are medical specialists in cardiology, cardiovascular diseases, and others from around the world. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)

Leading interventional cardiologists, including Patrick Serruys, Eric Topol, David Holmes, Thomas Luscher and others provide the gold-standard reference on the treatment of restenosis (coronary artery blockage) for interventional cardiologists. Dr. Serruys, who pioneered the use of drug-eluting stents, and other pioneers in the field cover everything from non-invasive imaging, to eluting stents, to brachytherapy through to the latest molecular biology-based treatments including antisense, stem cells and gene therapy, making this an essential reference for all interventional cardiologists.

Leading interventional cardiologists, including Patrick Serruys, provide the gold-standard reference on the treatment of restenosis for interventional cardiologists. Dr. Serruys, who pioneered the use of drug-eluting stents, and other pioneers in the field, cover everything from non-invasive imaging, to eluting stents, to brachytherapy through to the latest molecular biology-based treatments including antisense, stem cells and gene therapy.

Recenzijas

From the reviews:









"This is a comprehensive review of the problem of restenosis, from the basic science to clinical management. The audience includes interventional cardiology fellows and interventional cardiologists. The book describes the difficulties that cardiologists face trying to prevent and manage restenosis. Each chapter includes extensive references. This is a complete, state-of-the-art review of restenosis, covering all aspects of restenosis from pathophysiology to therapeutic management. The authors are leaders in interventional cardiology with extensive clinical experience in the field." (Adriana Maria Rosario, Doodys Review Service, December, 2007)



"A multiauthored, comprehensive compendium of virtually all aspects of the restenotic process after balloon- or stent-induced arterial injury. ... The text is written by a blueribbon panel of authors who provide an in-depth coverage of the topics. Many of the clinical chapters offer an excellent historical perspective on the problem of restenotis. ... Recommended Readership: Interventional (clinical and research) cardiologists and interventional fellows." (John F. Bresnahan, Mayo Clinic Proceedings, Vol. 83 (4), April, 2008)

Preface v
Contributors ix
List of Color Plates
xiii
Part I. Pathophysiology and Diagnosis
Unraveling the Complex Process of Restenosis From Bench to Bedside
3(4)
Henricus J. Duckers
Caroline Cheng
Dennie Tempel
Patrick W. Serruys
Epidemiology and Pathogenesis of Restenosis
7(22)
Randolph L. Geary
Alexander W. Clowes
Clinical Presentation of Restenosis
29(18)
Ganesh Manoharan
Giedrius Davidavicius
William Wijns
Pathological Anatomy of Restenosis
47(12)
Renu Virmani
Frank D. Kolodgie
Aloke V. Finn
Herman K. Gold
The Influence of Shear Stress on Restenosis
59(26)
Attila Thury
Jolanda J. Wentzel
Frank J. H. Gijsen
Johan C. H. Schuurbiers
Rob Krams
Pim J. de Feyter
Patrick W. Serruys
Cornelis J. Slager
The Immune System in the Pathogenesis of Vascular Proliferative Disease
85(46)
Jon D. Laman
Burkhard Ludewig
Animal Restenosis Models: From the Ideal Model to the Ideal Study
131(22)
Arturo G. Touchard
Robert S. Schwartz
Part II. Genetic Basis of Restenosis
The Genomics of Restenosis
153(14)
Thomas W. Johnson
Karl R. Karsch
Gene-Expression Profiling and Restenosis
167(8)
Dietlind Zohlnhofer
Franz-Josef Neumann
Proteomics and Restenosis
175(10)
Santhi K. Ganesh
Elizabeth G. Nabel
Contribution of Circulating Progenitor Cells to Vascular Repair and Lesion Formation
185(14)
Masataka Sata
Kenneth Walsh
Cell Cycle Regulators and Vascular Proliferative Diseases
199(14)
Andrew Wragg
Manfred Boehm
Arterial Remodeling
213(14)
Gerard Pasterkamp
Bradley H. Strauss
Dominique de Kleijn
The Role of eNOS in Vascular Diseases
227(20)
Alexey Kuroedov
Francesco Cosentino
Felix C. Tanner
Thomas F. Luscher
Part III. Diagnosis of Restenosis
The Use of Pressure Gradient in the Diagnosis of Restenosis
247(10)
Volker Klaus
Nico H. J. Pijls
The Use of Radio Isotopes in the Diagnosis of Vascular Proliferative Disease
257(20)
Giedrius Davidavicius
Ganesh Manoharan
William Wijns
Magnetic Resonance Imaging for Restenosis
277(10)
Robert Jan M. van Geuns
Timo Baks
Coronary Imaging With Multislice Spiral Computed Tomography
287(14)
Koen Nieman
Part IV. Therapy of Restenosis
Pharmacotherapy of Restenosis
301(6)
Pim J. de Feyter
Georgios Sianos
Brachytherapy
307(26)
Ron Waksman
Preclinical Data of Eluting Stents
333(20)
Antonio Colombo
Alaide Chieffo
Clinical Data of Eluting Stents
353(16)
Marco A. Costa
Alexandre Abizaid
Amanda G. M. R. Sousa
J. Eduardo Sousa
Biodegradable Stents
369(10)
Takafumi Tsuji
Hideo Tamai
Keiji Igaki
Part V. Biotechnology in the Treatment of Restenosis
Vascular Gene Therapy
379(16)
Gurpreet S. Sandhu
Robert D. Simari
Antisense and ODN Transcription Factors in the Treatment of Vascular Proliferative Disease
395(12)
Nicholas Kipshidze
Mykola Tsapenko
George Dangas
Pat Iversen
Cell Cycle Approaches to the Treatment of In-Stent Restenosis
407(12)
Elizabeth G. Nabel
Local Gene and Cell Delivery Devices
419(24)
Ravish Sachar
Eric J. Topol
Index 443